Stocks
Aerie Pharmaceuticals (AERI) EV/EBITDA US GAAP (year values) |
|||||||||
| 2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -13.9 | -5.72 | -5.91 | -5.08 | -57.1 | -290.4 | ||
| Changes by years, y/y, % | +34% | -59% | +3% | -14% | +1 025% | +40.7% | |||
Aerie Pharmaceuticals. EV/EBITDA
Aerie Pharmaceuticals. EV/EBITDA, changes, %
Aerie Pharmaceuticals (AERI) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | 2022Q3 | LTM ? | |||
| EV/EBITDA | ? | -6.40 | -57.4 | -49.3 | -127.2 | -288.9 | -290.4 | |
| Changes by years, y/y, % | +54% | +1 034% | +539% | +1 479% | +4 414% | |||
| Changes by quarters, q/q, % | -21% | +797% | -14% | +158% | +127% | |||
